Bridge Funding Award

Organization
Rivkin Center
Type
Foundation
Application or LOI Due Date
10-15-2020
Comments
Call for applications will open September 1, 2020. Deadline for submission is October 15, 2020 at 5pm EST.
Brief Description

About the Program

Federal funding for research is tighter than ever, and often researchers do not get funded on their first try with a new proposal. The purpose of Bridge Funding is to allow researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. In order to be competitive, resubmitted proposals must include solid data and address the concerns of expert reviewers. The Rivkin Center provides interim funding of up to $30,000 for six months to researchers who have submitted to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who were not funded but received a score close to the funding threshold. With more data, ovarian cancer researchers stand a better chance of being successfully funded with a stronger, resubmitted proposal.

Program Details

Bridge Funding allows researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. The Rivkin Center provides interim funding of up to $30,000 to researchers who have submitted an R01 or R21 proposal to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who have not received, but were close to, a fundable score.